375 related articles for article (PubMed ID: 32499554)
1. Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China.
Liu D; Kuai Y; Zhu R; Zhou C; Tao Y; Han W; Chen Q
Sci Rep; 2020 Jun; 10(1):9104. PubMed ID: 32499554
[TBL] [Abstract][Full Text] [Related]
2. Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level < 4 ng/ml: a population-based study.
Zheng Z; Zhou Z; Yan W; Zhou Y; Chen C; Li H; Ji Z
BMC Cancer; 2020 Apr; 20(1):340. PubMed ID: 32321456
[TBL] [Abstract][Full Text] [Related]
3. How socioeconomic and clinical factors impact prostate-cancer-specific and other-cause mortality in prostate cancer stratified by clinical stage: Competing-risk analysis.
He H; Han D; Xu F; Lyu J
Prostate; 2022 Mar; 82(4):415-424. PubMed ID: 34927741
[TBL] [Abstract][Full Text] [Related]
4. Risk factor analysis and nomogram construction in patients with distant metastatic prostate cancer at different PSA levels: a study based on the SEER database.
Li HD; Fan SQ; Qin F; Zhao ST; Kong SP; Ma JG
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2372-2386. PubMed ID: 38567600
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. A study on the impact of marital status on the survival status of prostate cancer patients based on propensity score matching.
Chen Q; Zhu X; Hu Y; Chen Y; Dai R; Li J; Zhuang J; Lin Y; Zeng Y; You L; Zeng Y; Huang Q
Sci Rep; 2024 Mar; 14(1):6162. PubMed ID: 38485743
[TBL] [Abstract][Full Text] [Related]
7. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.
Kamiya N; Suzuki H; Yano M; Endo T; Takano M; Komaru A; Kawamura K; Sekita N; Imamoto T; Ichikawa T
Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975
[TBL] [Abstract][Full Text] [Related]
8. Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL.
Ang M; Rajcic B; Foreman D; Moretti K; O'Callaghan ME
BJU Int; 2016 Apr; 117 Suppl 4():68-75. PubMed ID: 26890320
[TBL] [Abstract][Full Text] [Related]
9. Marital status and prostate cancer outcomes.
Tyson MD; Andrews PE; Etzioni DA; Ferrigni RG; Humphreys MR; Swanson SK; Castle EK
Can J Urol; 2013 Apr; 20(2):6702-6. PubMed ID: 23587510
[TBL] [Abstract][Full Text] [Related]
10. Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy.
Miyamoto S; Ito K; Miyakubo M; Suzuki R; Yamamoto T; Suzuki K; Suzuki K; Yamanaka H
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):75-86. PubMed ID: 21986985
[TBL] [Abstract][Full Text] [Related]
11. Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study.
Wu YP; Chen SH; Wang ST; Li XD; Cai H; Lin YZ; Xue XY; Wei Y; Zheng QS; Xu N
Oncotarget; 2017 Apr; 8(17):29048-29055. PubMed ID: 28423709
[TBL] [Abstract][Full Text] [Related]
12. Do Prostate Cancer Patients With Markedly Elevated PSA Benefit From Radiation Therapy?: A Population-based Study.
Lawrence YR; Samueli B; Levitin R; Pail O; Spieler B; Pfeffer R; Goldstein J; Den RB; Symon Z
Am J Clin Oncol; 2017 Dec; 40(6):605-611. PubMed ID: 26125304
[TBL] [Abstract][Full Text] [Related]
13. Competing risk of the specific mortality among Asian-American patients with prostate cancer: a surveillance, epidemiology, and end results analysis.
Wu D; Yang Y; Jiang M; Yao R
BMC Urol; 2022 Mar; 22(1):42. PubMed ID: 35331219
[TBL] [Abstract][Full Text] [Related]
14. Marital Status and Survival in Osteosarcoma Patients: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
Qiu S; Tao L; Zhu Y
Med Sci Monit; 2019 Nov; 25():8190-8203. PubMed ID: 31672959
[TBL] [Abstract][Full Text] [Related]
15. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
Culp SH; Schellhammer PF; Williams MB
Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of Gleason scores in metastatic prostate cancer.
Rusthoven CG; Carlson JA; Waxweiler TV; Yeh N; Raben D; Flaig TW; Kavanagh BD
Urol Oncol; 2014 Jul; 32(5):707-13. PubMed ID: 24629494
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of web-based nomograms for detecting and prognosticating in prostate adenocarcinoma with bone metastasis.
Dong Q; Wu X; Gan W; Mok TN; Shen J; Zha Z; Chen J
Sci Rep; 2022 Nov; 12(1):18623. PubMed ID: 36329203
[TBL] [Abstract][Full Text] [Related]
18. Associations of Prostate-Specific Antigen, Prostate Carcinoma Tissue Gleason Score, and Androgen Receptor Expression with Bone Metastasis in Patients with Prostate Carcinoma.
Chen Y; Lin Y; Nie P; Jiang W; Liu Y; Yuan R; Li M; Zhao S; Lin H; Li P; Zhang J; Hu Z; Xu J; Zhu X
Med Sci Monit; 2017 Apr; 23():1768-1774. PubMed ID: 28400549
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Positive Bone Metastasis in Newly Diagnosed Prostate Cancer Patients.
Chien TM; Lu YM; Geng JH; Huang TY; Ke HL; Huang CN; Li CC; Chou YH; Wu WJ; Huang SP
Asian Pac J Cancer Prev; 2016; 17(3):1187-91. PubMed ID: 27039746
[TBL] [Abstract][Full Text] [Related]
20. PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitions.
Deuker M; Stolzenbach LF; Pecoraro A; Rosiello G; Luzzago S; Tian Z; Saad F; Chun FK; Karakiewicz PI
World J Urol; 2021 Mar; 39(3):787-796. PubMed ID: 32458094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
